期刊文献+

醛糖还原酶抑制剂对大鼠肾脏醛糖还原酶基因表达的影响 被引量:4

Effect of aldose reductase inhibitor on rat kidney aldose reductase gene expression
下载PDF
导出
摘要 目的:观察醛糖还原酶抑制剂(ARI)依帕司他对大鼠肾脏ARmRNA水平和肾功能相关指标的影响。方法:运用在单侧肾结扎的基础上注射STZ的方法建立大鼠糖尿病肾病模型,给予醛糖还原酶抑制剂依帕司他灌胃4周,RT-PCR的方法检测各组大鼠肾皮质ARmRNA水平,观察依帕司他对ARmRNA是否有影响以及血清和尿液中尿素氮(BUN)、肌酐(Cr)和总蛋白(TP)的变化。结果:给药组大鼠肾脏ARmRNA水平明显高于对照组(P<0.05);给予醛糖还原酶抑制剂依帕司他4周后,低剂量组(L组)、高剂量组(H组)ARmRNA水平低于模型对照组(M组)(P<0.05),但L组和H组之间没有差别(P>0.05)。结论:糖尿病肾病大鼠肾脏ARmRNA水平明显升高,说明AR与糖尿病肾病的发生有关;醛糖还原酶抑制剂依帕司他对糖尿病肾病大鼠肾功能没有影响,但可降低ARmRNA水平。 Objective: To investigate the effect of an aldose reductase inhibitor (ARI)-epalrestat on AR mRNA level of rat kidney and renal function. Methods: To establish the diabetic nephropathy animal model by an injection of streptozotocin following unilateral kidney ligation. There are four groups including control group, model group, low dose group and high dose group. Low dose group and high dose group was given aldose reductase inhibitor epalrestat 50 mg/kg and 100 mg/kg respectively by intragastric administration, which last for 4 weeks. The level of AR mRNA of rat kidney was analyzed by quantitatively RT-PCR method and evaluate the effect of epalrestat on AR mRNA level between groups. Results: The level of renal function is significantly different between diabetic nephropathy groups and normal controls, but there is no significant difference between the groups given epalrestat and groups without epalrestat. AR mRNA level in rat kidney of diabetic nephropathy is significantly higher than that in rat kidney of normal controls. After given epalrestat 4 weeks, the level of AR mRNA decrease, but there is no significant difference between low dose groups and high dose groups. Conclusion: Rats with diabetic nephropathy have a significantly higher expression of AR mRNA in kidney than normal controls. Epalrestat have no effect on renal function of rats with diabetic nephropathy, but AR mRNA level decrease after given epalrestat for 4 weeks. Rats rendered diabetic by an injection of streptozocin, following half kidney ligation, are an excellent model of diabetic nephropathy.
出处 《天津医科大学学报》 2005年第4期519-521,共3页 Journal of Tianjin Medical University
基金 天津市自然科学基金资助(编号:023611211)
关键词 醛糖还原酶 醛糖还原酶抑制剂 糖尿病肾病 基因表达 Aldose Reductase, Aldose reductase inhibitor Diabetic nephropathy Gene expression
  • 相关文献

参考文献6

  • 1Ghahary A,Luo JM,Gong YW,et al.Increased renal aldose reductase activity,immunoreactivity,and mRNA in streptozotocin-induced diabetic rats[J].Diabetes,1989,38:1067. 被引量:1
  • 2Kasajima H,Yamagishi S,Sugai S,et al.Enhanced in situ expression of aldose reductase in peripheral nerve and renal glomeruli in diabetic patients[J].Virchows Arch,2001,439:46. 被引量:1
  • 3Iso K,Tada H,Kuboki K,et al.Long-term effect of epalrestat,an aldose reductase inhibitor,on the development of incipient diabetic nephropathy in type 2 diabetic patients[J].Diabetes Complications,2001,15:241. 被引量:1
  • 4Yokozama T,Nakagawa T,Wakaki K,et al.Animal model of diabetic nephropathy[J].Exp Toxic Pathol,2001,53:359. 被引量:1
  • 5Obrosova IG,Van Huysen C,Fathallah L,et al.An aldose reductase inhibitor reverses early diabetes-induced changes in peripheral nerve functions,metabolism and antioxidative defense [J].FASEB ,2001,11:14. 被引量:1
  • 6Kamiya H,Nakamura J,Hamada Y,et al.Polyol pathway and protein kinase C activity of rat Schwannoma cells [J].Diabetes Metab Res Rev,2003,19:131. 被引量:1

同被引文献32

引证文献4

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部